ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
10 announcements with these filters
Quick Heal Technologies Limited shareholders approved the re-appointment of Mr. Richard Stiennon as a Non-Executive Independent Director for a second five-year term, effective September 27, 2026.
Quick Heal Technologies held its 31st Annual General Meeting on September 23, 2026, to conduct business, including the adoption of financial statements and director appointments.
Quick Heal Technologies' Chief Marketing Officer, Sudhanshu Tripathi, has resigned from the company effective September 16, 2026, to pursue other professional opportunities.
Quick Heal Technologies responded to NSE's volume-spurt query, stating all Reg 30 disclosures were made. The company attributes the increase to normal market forces with no undisclosed material event.
Quick Heal Technologies Limited has allotted 9,746 equity shares following the exercise of options under its ESOP Scheme 2021. The exercise prices ranged from ₹114 to ₹122.
Quick Heal Technologies Ltd has appointed Mr. Amit Chaudhary as Vice President – Product Management. This appointment is effective from September 01, 2026.
Quick Heal Technologies Limited has shared the link to its Integrated Annual Report for FY 2025-26 and reminded shareholders to update their KYC details.
Quick Heal Technologies filed its Integrated Annual Report for FY 2025-26. The company also announced its 31st AGM scheduled for September 23, 2026.
Quick Heal Technologies Limited has scheduled its 31st Annual General Meeting for September 23, 2026. The meeting will be conducted via video conferencing with remote e-voting available.
Quick Heal Technologies Limited has approved the grant of 1,02,000 employee stock options under its ESOP Scheme 2021. These options are exercisable at ₹76 per share.